These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 3474052)

  • 1. Intensive treatment of acute leukemia in adults 70 years of age and older.
    Walters RS; Kantarjian HM; Keating MJ; Estey EH; McCredie KB; Freireich EJ
    Cancer; 1987 Jul; 60(2):149-55. PubMed ID: 3474052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A four-year experience with anthracycline, cytosine arabinoside, vincristine and prednisone combination chemotherapy in 325 adults with acute leukemia.
    Keating MJ; Smith TL; McCredie KB; Bodey GP; Hersh EM; Gutterman JU; Gehan E; Freireich EJ
    Cancer; 1981 Jun; 47(12):2779-88. PubMed ID: 6942906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA as a carrier for anthracyclines in the treatment of acute myelocytic leukemia (AML).
    Gahrton G; Tidefelt U; Paul C; Björkholm M; Grimfors G; Hast R; Juliusson G; Järnmark M; Killander A; Kimby E
    Leukemia; 1992; 6 Suppl 2():89-91. PubMed ID: 1578953
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapy of acute myelogenous leukemia in patients over the age of 50: a randomized Southeastern Cancer Study Group trial.
    Stein RS; Vogler WR; Winton EF; Cohen HJ; Raney MR; Bartolucci A
    Leuk Res; 1990; 14(10):895-903. PubMed ID: 2259226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early intensification and short-term maintenance chemotherapy does not prolong survival in acute myelogenous leukemia.
    Kantarjian HM; Keating MJ; Walters RS; McCredie KB; Bodey GP; Freireich EJ
    Cancer; 1986 Oct; 58(8):1603-8. PubMed ID: 3463390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of results of salvage therapy in adult acute myelogenous leukemia.
    Keating MJ; Estey E; Kantarjian HM; Walters R; Smith T; McCredie KB; Freireich EJ
    Acta Haematol; 1987; 78 Suppl 1():120-6. PubMed ID: 3124434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission of rheumatoid arthritis with the successful treatment of acute myelogenous leukemia with cytosine arabinoside, daunorubicin, and m-AMSA.
    Roubenoff R; Jones RJ; Karp JE; Stevens MB
    Arthritis Rheum; 1987 Oct; 30(10):1187-90. PubMed ID: 3479115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission induction and postremission therapy in acute myelogenous leukemia: British MRC Study.
    Rees JK; Gray RG
    Haematol Blood Transfus; 1990; 33():243-8. PubMed ID: 1691131
    [No Abstract]   [Full Text] [Related]  

  • 9. Amsacrine and continuous-infusion high-dose cytosine arabinoside as induction therapy for patients with newly-diagnosed acute myelogenous leukemia.
    Ghaddar HM; Pierce S; Kantarjian HM; Freireich EJ; Keating MJ; Estey EH
    Leuk Lymphoma; 1996 Jun; 22(1-2):71-6. PubMed ID: 8724530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult acute leukaemia.
    Atkinson K; Wells DG; Clink HM; Kay HE; Powles R; McElwain TJ
    Br J Cancer; 1974 Sep; 30(3):272-8. PubMed ID: 4141625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose cytosine arabinoside and daunorubicin as primary therapy in elderly patients with acute myelogenous leukemia. A phase I-II study of the Southeastern Cancer Study Group.
    Lazarus HM; Vogler WR; Burns CP; Winton EF
    Cancer; 1989 Mar; 63(6):1055-9. PubMed ID: 2917307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of adult acute lymphoblastic leukemia. Preliminary results of a trial from the French Group.
    Fière D; Archimbaud E; Extra JM; Marty M; David B; Witz F; Sotto JJ; Rochant H; Gastaut JA; Le Prise PY
    Haematol Blood Transfus; 1987; 30():125-9. PubMed ID: 3305189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ninth British Medical Research Council trial for the treatment of acute myeloid leukaemia.
    Rees JK; Gray R; Hayhoe FG
    Haematol Blood Transfus; 1987; 30():35-7. PubMed ID: 2442075
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative analysis of 3 therapeutic regimens based on the combination of an anthracycline and cytosine arabinoside for remission induction in myeloblastic leukemia].
    Sanz MA; Lorenzo JI; Sanz GF; Martín Aragonés G; Rafecas FJ; Martínez JA; Gomis F
    Sangre (Barc); 1988 Dec; 33(6):497-504. PubMed ID: 3247626
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term follow-up of a randomized post-induction therapy trial in acute myelogenous leukemia (a Southeastern Cancer Study Group trial).
    Volger WR; Weiner RS; Moore JO; Omura GA; Bartolucci AA; Stagg M
    Leukemia; 1995 Sep; 9(9):1456-60. PubMed ID: 7544851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of acute nonlymphocytic leukemia induction chemotherapy in acute lymphocytic leukemia.
    Cassileth PA; Bennett JM
    Cancer Treat Rep; 1985 Dec; 69(12):1439-40. PubMed ID: 3865702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete remission in prolymphocytic leukemia with 4-demethoxydaunorubicin and arabinosyl cytosine.
    Lambertenghi-Deliliers G; Maiolo AT; Annaloro C; Pogliani E; Baldini L; Polli E
    Cancer; 1984 Jul; 54(2):199-201. PubMed ID: 6586276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of various types of acute leukemia in adult. An analysis of 98 cases. The Leukemia Cooperation Group of Beijing City].
    Zhonghua Nei Ke Za Zhi; 1992 Mar; 31(3):139-42, 187. PubMed ID: 1395923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, Denmark.
    Hansen OP; Pedersen-Bjergaard J; Ellegaard J; Brincker H; Boesen AM; Christensen BE; Drivsholm A; Hippe E; Jans H; Jensen KB
    Leukemia; 1991 Jun; 5(6):510-6. PubMed ID: 2056774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute promyelocytic leukemia. M.D. Anderson Hospital experience.
    Kantarjian HM; Keating MJ; Walters RS; Estey EH; McCredie KB; Smith TL; Dalton WT; Cork A; Trujillo JM; Freireich EJ
    Am J Med; 1986 May; 80(5):789-97. PubMed ID: 3458366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.